Danaher initiates stock sale to help finance $21B GE Biopharma acquisition

Washington Business Journal

Sep 5, 2019

D.C.-based Danaher Corp. (NYSE: DHR) is initiating a stock sale to finance its $21 billion acquisition of General Electric Co.'s biopharma business. The company said Tuesday it exp…